New immunosuppressive approaches: Oral administration of CD3-specific antibody to treat autoimmunity
- 15 November 2008
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 274 (1-2), 9-12
- https://doi.org/10.1016/j.jns.2008.07.027
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- CD3-specific antibodies: a portal to the treatment of autoimmunityNature Reviews Immunology, 2007
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- CD3-Specific Antibodies as Promising Tools to Aim at Immune Tolerance in the ClinicInternational Reviews of Immunology, 2006
- CD3-specific antibody-induced active tolerance: from bench to bedsideNature Reviews Immunology, 2003
- Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune EncephalomyelitisScience, 1994
- INDUCTION OF LONG-TERM SPECIFIC TOLERANCE TO ALLOGRAFTS IN RATS BY THERAPY WITH AN ANTI-CD3-LIKE MONOCLONAL ANTIBODYTransplantation, 1993
- Hypothermia and hypoglycemia induced by anti‐CD3 monoclonal antibody in mice: Role of tumor necrosis factorEuropean Journal of Immunology, 1990
- Protection by Milk Immunoglobulin Concentrate against Oral Challenge with EnterotoxigenicEscherichia coliNew England Journal of Medicine, 1988
- Human in vivo antigenic modulation induced by the anti‐T cell OKT3 monoclonal antibodyEuropean Journal of Immunology, 1982
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal AllograftsNew England Journal of Medicine, 1981